Tuoli Xiaodu San Alleviates Ferroptosis in Ulcerative Colitis via Suppression of the DUOX2/GPX4 Axis
Journal of Inflammation Research · 2026-10 · Volume 19 · 1-15
DOI: 10.2147/jir.s594705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-10. Verfasst von Zhaozheng Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215009, People's Republic of Chin…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
To investigate the therapeutic effect of Tuoli Xiaodu San (TLXDS) on ulcerative colitis (UC) and identify its key molecular target.
Methods
A murine UC model was established to evaluate TLXDS effects. In addition, in vitro experiments using LPS-induced MODE-K cells were performed to further validate the underlying mechanism of TLXDS active compounds. Network pharmacology and differential gene analysis identified DUOX2 as a potential target and quercetin (Que), a major flavonoid active component of TLXDS, as a key candidate compound. Subsequent RT-qPCR, immunohistochemistry, transmission electron microscopy (TEM) analysis of mitochondrial ultrastructural changes, measurement of Fe2+ content and oxidative stress markers (SOD, MDA, GSH), ROS detection, and Western blot of GPX4 and SLC7A11 expression were conducted to validate the role of DUOX2 in TLXDS-mediated ferroptotic alleviation in UC. A DUOX2 overexpression model was constructed to assess its impact on the anti-inflammatory and anti-ferroptotic effects of TLXDS. Furthermore, the effects of both TLXDS-containing serum and Que were evaluated in LPS-induced MODE-K cells.
Results
TLXDS significantly ameliorated body weight loss and elevated disease activity index in UC mice, attenuated colon tissue damage, and reduced IL-6, TNF-α, and IL-1β levels. TLXDS treatment suppressed DUOX2 overexpression in the colon tissue of UC mice, reduced Fe2+ accumulation, enhanced SOD and GSH levels, decreased MDA levels and ROS production, and alleviated ferroptosis-associated mitochondrial ultrastructural damage, while upregulating GPX4 and SLC7A11. The anti-inflammatory and anti-ferroptotic effects of TLXDS were attenuated upon DUOX2 overexpression. Furthermore, in vitro experiments demonstrated that both TLXDS-containing serum and Que similarly reduced inflammation, iron accumulation, and oxidative stress in cells via the DUOX2/GPX4 pathway.
Conclusion
TLXDS alleviates UC by inhibiting DUOX2 overexpression, subsequently reducing inflammation and ferroptosis. DUOX2 may serve as a key therapeutic target for TLXDS. Integrating network pharmacology with in vivo experiments provides novel molecular insights into traditional Chinese medicine for UC treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215009, People's Republic of China.
ORCID-Profile: Zhaozheng Zhang
Zitieren
APA
Zhang, Z., Wang, X., Hou, M., Wen, K., & Yang, J. (2026). Tuoli Xiaodu San Alleviates Ferroptosis in Ulcerative Colitis via Suppression of the DUOX2/GPX4 Axis. Journal of Inflammation Research, Volume 19, 1-15. https://doi.org/10.2147/jir.s594705
Vancouver
Zhang Z, Wang X, Hou M, Wen K, Yang J. Tuoli Xiaodu San Alleviates Ferroptosis in Ulcerative Colitis via Suppression of the DUOX2/GPX4 Axis. Journal of Inflammation Research. 2026;Volume 19:1-15. doi:10.2147/jir.s594705
BibTeX
@article{Zhang2026,
author = {Zhang, Zhaozheng and Wang, Xuejiao and Hou, Mengru and Wen, Ke and Yang, Jianhua},
title = {Tuoli Xiaodu San Alleviates Ferroptosis in Ulcerative Colitis via Suppression of the DUOX2/GPX4 Axis},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--15},
doi = {10.2147/jir.s594705}
}
EUVIMED